Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 11:18:1705-1717.
doi: 10.2147/CIA.S414799. eCollection 2023.

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years - A Review of Published Literature

Alia J Codelia-Anjum #  1 , Mohamad Baker Berjaoui #  2 , Adree Khondker  2 , Dean Elterman  2 , Kevin C Zorn  3 , Naeem Bhojani  3 , Lori B Lerner  4 , Bilal Chughtai  1
Affiliations
Review

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years - A Review of Published Literature

Alia J Codelia-Anjum et al. Clin Interv Aging. .

Abstract

Objective: We set out to review studies reporting on the use of surgical intervention to treat Benign Prostatic Hyperplasia in elderly men ≥70 years of age.

Methods: A systematic literature search was conducted using Scopus, PubMed-MEDLINE, Cochrane, and Wiley Online Library databases including studies published between January 2012 through December 2022. This 10-year interval was chosen given the recent plethora of new modalities that have entered the BPH armamentarium, many of which have been marketed as appropriate for older and high-risk patients. The following database search words were used either individually or in conjunction: "BPH", "elderly", "surgical", "ablation", "resection", "embolization", and "aging".

Results: We identified 28 studies for inclusion in this review. The pros and cons of these modalities are presented, specifically as applicable to an older and higher risk population.

Conclusion: There are a wide variety of surgical procedures available for surgically treating BPH in elderly men with varying states of health. Each of these comes with different risks and benefits, supporting that individualized approaches are important. Long-term data and further studies comparing modalities, specifically as regards the elderly and frail, would enhance our approaches to BPH treatment in this patient population.

Keywords: aging; benign prostatic hyperplasia; elderly; surgical.

PubMed Disclaimer

Conflict of interest statement

Bilal Chughtai is a consultant for Olympus, Boston Scientific, Ferring Pharmaceuticals, and Allergan. Dean Elterman reports grants, personal fees from Boston Scientific, grants from Olympus, grants from Urotronic, grants from Procept Biorobotics, grants from Zenflow, outside the submitted work. Kevin C. Zorn is a consultant and proctor for Boston Scientific, Procept BioRobotics, and investigator for Zenflow. Naeem Bhojani is a consultant for Olympus, Boston Scientific, and Procept BioRobotics. Lori Lerner reports Uncompensated - Chair of the Clinical Events Committee (CEC) from Proverum, outside the submitted work. The authors declare that they have no other known competing interests.

Figures

Figure 1
Figure 1
Study selection flow diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bushman W. Etiology, epidemiology, and natural history. Urol Clin North Am. 2009;36(4):403–415. doi:10.1016/j.ucl.2009.07.003 - DOI - PubMed
    1. Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II—surgical evaluation and treatment. J Urol. 2021;206(4):818–826. doi:10.1097/ju.0000000000002184 - DOI - PubMed
    1. Bortnick E, Brown C, Simma-Chiang V, Kaplan SA. Modern best practice in the management of benign prostatic hyperplasia in the elderly. Ther Adv Urol. 2020;12. doi:10.1177/1756287220929486 - DOI - PMC - PubMed
    1. Lotterstätter M, Seklehner S, Wimpissinger F, et al. Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study. World J Urol. 2022;40(12):3015–3020. doi:10.1007/s00345-022-04179-w - DOI - PMC - PubMed
    1. Yang EJ, Li H, Sun XB, et al. Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk. Sci Rep. 2016;6(1). doi:10.1038/srep21494 - DOI - PMC - PubMed